| Human |
hsa_circ_CSNK1G3 |
hsa_circ_0001522 |
circCSNK1G3 |
prostate cancer |
CSNK1G3 |
- |
Q
M
| DN |
More |
| Human |
hsa_circ_CSNK1G3 |
hsa_circ_0001522 |
circCSNK1G3 |
renal cell carcinoma |
CSNK1G3 |
miR-181b |
Q
S
| UP |
More |
| Human |
hsa_circ_CSNK1G3 |
hsa_circ_0001522 |
circCSNK1G3 |
lung adenocarcinoma |
CSNK1G3 |
miR-143-3p |
Q
M
| UP |
More |
| Human |
hsa_circ_CSNK1G3 |
- |
circCSNK1G3 |
glioma |
CSNK1G3 |
miR-181d |
Q
| UP |
More |
| Human |
hsa_circ_CSNK1G3 |
hsa_circ_0001522 |
hsa_circCSNK1G3_004 |
bronchopulmonary dysplasia |
CSNK1G3 |
- |
Q
S
| DS |
More |
| Human |
hsa_circ_CSNK1G3 |
hsa_circ_0001522 |
circ_0001522 |
triple-negative breast carcinoma |
CSNK1G3 |
miR-579-3p, miR-4458 |
Q
S
| UP |
More |
| Human |
hsa_circ_CSNK1G3 |
- |
circCSNK1G3 |
chronic lymphocytic leukemia/small lymphocytic lymphoma |
CSNK1G3 |
- |
Q
S
| DN |
More |
| Human |
hsa_circ_CSNK1G3 |
- |
circCSNK1G3 |
prostate cancer |
CSNK1G3 |
miR-181b, miR-181d |
Q
S
| UN |
More |
| Human |
hsa_circ_CSNK1G3 |
- |
circCSNK1G3 |
myelodysplastic syndrome |
CSNK1G3 |
Hsa-miR-409-3p, hsa-miR-579-5p, hsa-miR-1238-3p |
S
| UP |
More |